Albany Molecular Research, Inc.
| Nasdaq: AMRI
Albany Molecular Research, Inc. provides scientific services, technologies and products. It provides contract services platform encompassing drug discovery, development and manufacturing services. The company operates through three segments: Large Scale Manufacturing & Discovery and Drug Development & Small Scale Manufacturing. The Large Scale Manufacturing & Discovery Segment includes pilot to commercial scale production of active pharmaceutical ingredients and intermediates, sterile syringe and vial filling and high potency and controlled substance manufacturing. The Drug Development & Small Scale Manufacturing segment includes activities such as drug lead discovery, optimization, drug development and small scale commercial manufacturing. It operates in United States, Europe and Asia. The company was founded by Thomas E. D'Ambra on June 20, 1991 and is headquartered in Albany, NY.